mojserafim.ru bms stock forecast


BMS STOCK FORECAST

Analyst's Opinion · Consensus Rating. Bristol-Myers Squibb has received a consensus rating of Hold. · Price Target Upside/Downside. According to analysts'. Bristol-Myers Squibb's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to grow. The 16 analysts with month price forecasts for BMY stock have an average target of , with a low estimate of 50 and a high estimate of The average. Bristol-Myers Squibb stock would need to gain 1,% to reach $1, According to our Bristol-Myers Squibb stock forecast, the price of Bristol-Myers Squibb. On average, Wall Street analysts predict that Bristol Myers Squibb Co's share price could reach $ by Feb 6, The average Bristol Myers Squibb Co stock.

Analyst Recommendations on Bristol-Myers Squibb Company · Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $51 From $58, Maintains Equalweight Rating. Is Bristol-Myers Squibb Company stock A Buy? Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as. Bristol-Myers Squibb (BMY) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bristol is expected to increase in value after the next headline with the price projected to jump to or above. The average volatility of media hype impact. A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. According to analysts, Bristol-Myers Squibb's stock has a predicted upside of % based on their month stock forecasts. What analysts cover Bristol-Myers. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ BMY will report FY earnings on 01/30/ Yearly Estimates. Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. Bristol-Myers Squibb · Open. · Previous Close. · High. · Low. · 52 Week High. · 52 Week Low. · Beta. · TTM EPS Trend. (+. new home sales fell % to a seasonally adjusted annual rate of , in April, well below the Reuters consensus forecast of , A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals.

Bristol Myers Squibb Co. analyst ratings, historical stock prices, earnings estimates & actuals. BMY updated stock price target summary. 1-year stock price forecast. High $ % Median $ % Low $ % Current Price past 12 months next 12 months. BMY Competitors. Bristol-Myers Squibb Stock Forecast · Over the next 52 weeks, Bristol-Myers Squibb has on average historically risen by % based on the past 51 years of stock. Bristol-Myers Squibb Stock Forecast, BMY stock price prediction. Price target in 14 days: USD. The best long-term & short-term Bristol-Myers Squibb. In the most recent trading session, Bristol Myers Squibb (BMY) closed at $, indicating a % shift from the previous trading day. Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment The stock isn't nearly as risky as its low valuation suggests. Based on analysts offering 12 month price targets for BMY in the last 3 months. The average price target is $ with a high estimate of $68 and a low. Based on short-term price targets offered by 18 analysts, the average price target for Bristol Myers Squibb comes to $ The forecasts range from a low of. Analyst Forecast. According to 17 analysts, the average rating for BMY stock is "Hold." The month stock price forecast is $, which is an increase of.

Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BMY will report earnings. Bristol-Myers Squibb's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to grow. Key Stock Data · P/E Ratio (TTM). (03/08/24) · EPS (TTM). $ · Market Cap. $ B · Shares Outstanding. B · Public Float. B · Yield. %. Bristol-Myers Squibb Co BMY:NYSE · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date04/06/23 · 52 Week Low ·

52 Week Low And 5% Yield! - GREAT Time To BUY After STRONG Earnings?! - BMY Stock Analysis! -

See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions. According to Wall Street analysts, the average 1-year price target for BMY is USD with a low forecast of USD and a high forecast of USD. BMY reached its all-time high on Nov 30, with the price of USD, and its all-time low was USD and was reached on Oct 3, See other stocks.

blgi stock | latest nft


Copyright 2018-2024 Privice Policy Contacts